SAN FRANCISCO CITY CLINIC CLINICAL PROTOCOLS SEXUALLY TRANSMITTED DISEASES
... 1. Clotrimazole 1% cream twice daily x 7-14 days 2. Miconazole 2% cream twice daily x 7-14 days 3. Tolnaftate (tinactin) 1% cream twice daily x 7-14 days All are available without prescription. Creams should be applied in a thin layer twice a day until balanitis has resolved. Most cases should resol ...
... 1. Clotrimazole 1% cream twice daily x 7-14 days 2. Miconazole 2% cream twice daily x 7-14 days 3. Tolnaftate (tinactin) 1% cream twice daily x 7-14 days All are available without prescription. Creams should be applied in a thin layer twice a day until balanitis has resolved. Most cases should resol ...
MedPsy Pedersen Management Europace 2010
... shocks are a powerful risk marker for subsequent clinical events. In patients with a primary preventive ICD indication, both appropriate and inappropriate shocks are associated with a marked increase in mortality, particularly due to death from progressive heart failure.7,8 Possible explanations for ...
... shocks are a powerful risk marker for subsequent clinical events. In patients with a primary preventive ICD indication, both appropriate and inappropriate shocks are associated with a marked increase in mortality, particularly due to death from progressive heart failure.7,8 Possible explanations for ...
Chronic Obstructive Pulmonary Disease (COPD)
... • COPD prevalence continues to grow. COPD is the 4th leading cause of death in the U.S. The World Health Organization (WHO) estimated that more than 3 million people died of COPD in 2005.WHO It is the only chronic illness for which prevalence is projected to increase in the coming decades.HAL • Go ...
... • COPD prevalence continues to grow. COPD is the 4th leading cause of death in the U.S. The World Health Organization (WHO) estimated that more than 3 million people died of COPD in 2005.WHO It is the only chronic illness for which prevalence is projected to increase in the coming decades.HAL • Go ...
Word-dokument
... “The granting of this patent is very pleasing as it further strengthens Glactone Pharma’s position as a leader in the discovery and development of direct small-molecule STAT3 inhibitors,” said Martin Johansson, CEO of Glactone Pharma. The patent is the result of research by an interdisciplinary coll ...
... “The granting of this patent is very pleasing as it further strengthens Glactone Pharma’s position as a leader in the discovery and development of direct small-molecule STAT3 inhibitors,” said Martin Johansson, CEO of Glactone Pharma. The patent is the result of research by an interdisciplinary coll ...
Allergic Rhinitis - Michigan Medicine
... • Intranasal corticosteroids (prescription and OTC ) are the most potent medications available for treating allergic rhinitis [I A*]. They control itching, sneezing, rhinorrhea, and stuffiness in most patients, and may help ocular symptoms. They have a relatively good long-term safety profile. Gener ...
... • Intranasal corticosteroids (prescription and OTC ) are the most potent medications available for treating allergic rhinitis [I A*]. They control itching, sneezing, rhinorrhea, and stuffiness in most patients, and may help ocular symptoms. They have a relatively good long-term safety profile. Gener ...
Borderline Personality Disorder
... • Baez et. al. assessed the performance of adult individuals with BPD on Theory of the Mind, emotion regulation, and emotional functioning in an attempt to test the idea that ToM deficits and their variability in BPD would depend on more basic skills, such as executive functions and emotion recognit ...
... • Baez et. al. assessed the performance of adult individuals with BPD on Theory of the Mind, emotion regulation, and emotional functioning in an attempt to test the idea that ToM deficits and their variability in BPD would depend on more basic skills, such as executive functions and emotion recognit ...
v ARIA - De Gruyter
... of diverticulosis include: old age, low-fibre diet, and connective tissue diseases (8). The role of the lifestyle and environmental factors is also stressed. In theoretic models of pathogenesis of the disease, structural and functional intestinal disorders due to abnormal innervation, impaired neuro ...
... of diverticulosis include: old age, low-fibre diet, and connective tissue diseases (8). The role of the lifestyle and environmental factors is also stressed. In theoretic models of pathogenesis of the disease, structural and functional intestinal disorders due to abnormal innervation, impaired neuro ...
... few of these therapies have been researched in an attempt to verify the anecdotal claims. But the results have not conclusively identified these treatments as helpful for tinnitus. Amplification (Hearing Aids) Some with hearing loss experience tinnitus relief while wearing hearing aids. If a patient ...
Vaginitis
... The main symptoms and signs of candidiasis are discharge, itching, burning/irritation, erythema, edema and excoriation. Rarely is vulvar candidiasis seen without concomitant vaginal candidiasis. Not all patients have symptoms of yeast infection. The incidence of asymptomatic fungal carriage in the v ...
... The main symptoms and signs of candidiasis are discharge, itching, burning/irritation, erythema, edema and excoriation. Rarely is vulvar candidiasis seen without concomitant vaginal candidiasis. Not all patients have symptoms of yeast infection. The incidence of asymptomatic fungal carriage in the v ...
Glucocorticoids and invasive fungal infections - LIFE
... immune and inflammatory response processes. There is mounting evidence that several immunosuppressive and anti-inflammatory effects of glucocorticoids may be exerted through inhibition of NFB and other transcription factors.19–24 Glucocorticoids affect virtually every cell type involved in immune a ...
... immune and inflammatory response processes. There is mounting evidence that several immunosuppressive and anti-inflammatory effects of glucocorticoids may be exerted through inhibition of NFB and other transcription factors.19–24 Glucocorticoids affect virtually every cell type involved in immune a ...
Recent Advances in the Management of Hereditary Angioedema
... chromosome 11. C1 INH, a serine protease inhibitor (serpin), is a primary regulator of the complement and kinin systems. Deficiency of C1 INH leads to unregulated activation of bradykinin. Data from various studies1-3 indicate that bradykinin plays an important role in mediating HAE symptoms such as ...
... chromosome 11. C1 INH, a serine protease inhibitor (serpin), is a primary regulator of the complement and kinin systems. Deficiency of C1 INH leads to unregulated activation of bradykinin. Data from various studies1-3 indicate that bradykinin plays an important role in mediating HAE symptoms such as ...
Annual Report - Boston Foundation for Sight
... followed by the customization process, which was performed by Alan Kwok, OD. He has treated many patients who suffer from extremely dry eyes. “Whether someone has ocular graft-vs-host disease due to a stem cell tranplant or severe dry eye caused by other medical conditions, when the lacrimal gland n ...
... followed by the customization process, which was performed by Alan Kwok, OD. He has treated many patients who suffer from extremely dry eyes. “Whether someone has ocular graft-vs-host disease due to a stem cell tranplant or severe dry eye caused by other medical conditions, when the lacrimal gland n ...
Allergic Rhinitis - Office of Continuous Professional Development
... patients with multiple potential allergen sensitivities Therapy. The goal of therapy is to relieve symptoms. 1. Avoidance of allergens is the first step [I A*]. (See text for details). If avoidance fails: 2. An over-the-counter (OTC), non-sedating antihistamine (loratadine [Claritin], cetirizine ([Z ...
... patients with multiple potential allergen sensitivities Therapy. The goal of therapy is to relieve symptoms. 1. Avoidance of allergens is the first step [I A*]. (See text for details). If avoidance fails: 2. An over-the-counter (OTC), non-sedating antihistamine (loratadine [Claritin], cetirizine ([Z ...
Open resource
... eat on the local economy. Efficacy is of brief duration; inadequate for sustained operations. After initial 1- 2 weeks of protection, prophylaxis with antibiotics has been associated with increased incidence of diarrhea due to disruption of protective normal bowel flora and with emergence of drug-re ...
... eat on the local economy. Efficacy is of brief duration; inadequate for sustained operations. After initial 1- 2 weeks of protection, prophylaxis with antibiotics has been associated with increased incidence of diarrhea due to disruption of protective normal bowel flora and with emergence of drug-re ...
... Our operational definition for this group of patients, termed "glucocorticoid-resistant," includes those patients who have a prebronchodilator morning forced expiratory volume in one second (FEV1) <70% of predicted, and who fail to increase this pre-bronchodilator morning FEV1 measurement by 15% aft ...
HIGHLIGHTS OF PRESCRIBING INFORMATION
... Step 2: Calculate the approximate equivalent dose of oral hydrocodone based on the total daily dose of the current opioid using Table 1; 30 mg total daily dose of oxymorphone x 2 = 60 mg of oral hydrocodone daily. The daily dose should then be divided in half for administration every 12 hours. Step ...
... Step 2: Calculate the approximate equivalent dose of oral hydrocodone based on the total daily dose of the current opioid using Table 1; 30 mg total daily dose of oxymorphone x 2 = 60 mg of oral hydrocodone daily. The daily dose should then be divided in half for administration every 12 hours. Step ...
British HIV Association guidelines for the treatment of TB
... sensitive than tuberculin tests for detecting both active and latent disease in HIV-negative subjects. They are also more specific in Bacillus Calmette–Guérin (BCG)-vaccinated individuals. Although there are few data regarding their performance in HIV-infected patients, especially at low blood CD4 ...
... sensitive than tuberculin tests for detecting both active and latent disease in HIV-negative subjects. They are also more specific in Bacillus Calmette–Guérin (BCG)-vaccinated individuals. Although there are few data regarding their performance in HIV-infected patients, especially at low blood CD4 ...
Biofeedback - Society of Urologic Nurses and Associates
... with recurrent urinary incontinence, urinary tract infections, and vesicoureteral reflux. Many treatment programs typically utilize formal urodynamic studies to develop an inpatient treatment program. At CHOP, however, the initial evaluation and treatment of children with voiding dysfunction is on a ...
... with recurrent urinary incontinence, urinary tract infections, and vesicoureteral reflux. Many treatment programs typically utilize formal urodynamic studies to develop an inpatient treatment program. At CHOP, however, the initial evaluation and treatment of children with voiding dysfunction is on a ...
D’accord study (Dasatinib Combination for CLL with Refractory Disease)
... Chronic lymphocytic leukemia (CLL) is a CD5+ B-cell malignancy that is considered incurable1. Historically, the first-line treatment consisted of alkylating agents, which resulted in response rates in up to 70% of patients, but did not improve survival2. Treatment regimens with the nucleoside (purin ...
... Chronic lymphocytic leukemia (CLL) is a CD5+ B-cell malignancy that is considered incurable1. Historically, the first-line treatment consisted of alkylating agents, which resulted in response rates in up to 70% of patients, but did not improve survival2. Treatment regimens with the nucleoside (purin ...
Crohn`s Disease and Ulcerative Colitis Show Unique
... the subtypes UC and CD [2, 7-8]. Furthermore, investigators are starting to elucidate the nature of disordered T-cell microbial recognition and effector function in IBD [2- 3-4, 8]. Studies of cytokines and transcription factors present in IBD patients have demonstrated that the Th1 and Th2 cell lin ...
... the subtypes UC and CD [2, 7-8]. Furthermore, investigators are starting to elucidate the nature of disordered T-cell microbial recognition and effector function in IBD [2- 3-4, 8]. Studies of cytokines and transcription factors present in IBD patients have demonstrated that the Th1 and Th2 cell lin ...
Lumbar disc herniation: treatment
... to -0.018; NNH = -6 CI95%: -57 to -3) showing low safety in the use of these medications18 (B). ...
... to -0.018; NNH = -6 CI95%: -57 to -3) showing low safety in the use of these medications18 (B). ...
Cysticercosis: An Emerging Parasitic Disease
... form of dexamethasone or prednisolone, has demonstrated a more consistent therapeutic benefit for neurocysticercosis patients with seizures.2,28 Steroids should always be used before or on initiation of antihelminthic medications to blunt the inflammatory reaction that may result in increased seizur ...
... form of dexamethasone or prednisolone, has demonstrated a more consistent therapeutic benefit for neurocysticercosis patients with seizures.2,28 Steroids should always be used before or on initiation of antihelminthic medications to blunt the inflammatory reaction that may result in increased seizur ...
Misconceptions about Botox
... months with a lowered eyelid may think differently. Lowering of the upper brow or eyelid (ptosis) can occur after injection in the frown muscles. This may occur as late as two weeks after injection and is more common in older patients receiving Botox® for the first time. Patients are usually instruc ...
... months with a lowered eyelid may think differently. Lowering of the upper brow or eyelid (ptosis) can occur after injection in the frown muscles. This may occur as late as two weeks after injection and is more common in older patients receiving Botox® for the first time. Patients are usually instruc ...
Electroconvulsive Therapy and other Neurostimulation Techniques
... had not significantly changed by the end of the course (28.91). • SPW patients actually had lower MMSE scores at baseline (25.49) which had improved to the same post-treatment scores as UB at the end of the course (28.11). • It is hard to explain why the SPW patients had lower MMSE scores at baselin ...
... had not significantly changed by the end of the course (28.91). • SPW patients actually had lower MMSE scores at baseline (25.49) which had improved to the same post-treatment scores as UB at the end of the course (28.11). • It is hard to explain why the SPW patients had lower MMSE scores at baselin ...
Efficacy of romiplostim in patients with chronic immune
... has been shown to increase platelet counts in most patients with chronic ITP. We assessed the long-term administration of romiplostim in splenectomised and non-splenectomised patients with ITP. Methods In two parallel trials, 63 splenectomised and 62 non-splenectomised patients with ITP and a mean o ...
... has been shown to increase platelet counts in most patients with chronic ITP. We assessed the long-term administration of romiplostim in splenectomised and non-splenectomised patients with ITP. Methods In two parallel trials, 63 splenectomised and 62 non-splenectomised patients with ITP and a mean o ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.